IL6 and COVID-19: The findings of the study highlighted that plasma levels of TNF, interleukin-6, and interleukin-8 were considerably lower among COVID-19 patients than among septic shock patients with acute respiratory distress syndrome, which elucidates a lower acuteness of disease despite acute lung injury.